Jared Finger

Jared Finger is a highly experienced Principal Scientist currently at Thermo Fisher Scientific since December 2021, following the acquisition of PPD, where Jared has been focusing on enabling the development of new medicines. At PPD, starting in April 2020, Jared has served as Principal Scientist for Biopharmaceutical Method Development & Validations, managing projects related to analytical methods for biopharmaceutical and gene therapy compounds under cGMP regulations. Previously, Jared was Vice President and Manager of Characterization Services at Cell Line Genetics, Inc., directing workflow and enhancing laboratory procedures from January 2014 to April 2020. Jared's early career includes various roles in laboratory management and research at UW-Madison and Cell Line Genetics. Jared holds an MS in Biotechnology and a BS in Genetics, both from the University of Wisconsin-Madison.